Suppression of the tumorigenic phenotype in human oral squamous cell carcinoma cells by an ethanol extract derived from freeze-dried black raspberries

Nutrition and Cancer

Volumn 54, Issue 1, 2006, Pages 58-68

  Rodrigo, Kapila A ^a   Rawal, Yeshwant ^b   Renner, Robert J ^a   Schwartz, Steven J ^a   Tian, Qingguo ^a   Larsen, Peter E ^a   Mallery, Susan R ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c Department of Oral Maxillofacial Surgery and Pathology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BLACK RASPBERRY EXTRACT; CYTOKINE; NITRIC OXIDE SYNTHASE; PLANT EXTRACT; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; BLACK RASPBERRY; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CARCINOMA CELL; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CHEMOPROPHYLAXIS; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME REPRESSION; FREEZE DRYING; HUMAN; HUMAN CELL; MALE; MOUTH CARCINOMA; PHENOTYPE; RASPBERRY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CASPASES; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOPREVENTION; ENZYME ACTIVATION; ENZYME INHIBITORS; ETHANOL; FOOD PRESERVATION; FREEZE DRYING; FRUIT; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NITRIC OXIDE SYNTHASE; PHENOTYPE; PHYTOTHERAPY; PLANT EXTRACTS; ROSACEAE; TRANSGLUTAMINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RUBUS OCCIDENTALIS;

EID: 33746524853     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5401_7     Document Type: Conference Paper

References (42)

1. Forastierc AA: Head and neck cancer: overview of recent developments and future direction. Semin Oncol 27, 1-4, 2000.
2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, et al.: Cancer statistics, 2005. Cancer J Clin 55, 10-11, 2005.
3. Papadimitrakopoulou VA, Clayman GL, Shin DM, Myers JN, Gillenwater AM, et al.: Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg 125, 1083-1089, 1999.
4. Toma A, Bonelli L, Sartoris A, Mira E, Antonelli A, et al.: 13-cis Retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian head and neck chemoprevention study group. Oncol Rep 11, 1297-1305, 2004.
5. Shin DM, Mao L, Papadimitrakopoulou VM, Clayman G, El-Naggar A, et al.: Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression. JNCI 92, 69-73, 2000.
6. Rudin CM, Cohen EEW, Papadimitrakopoulou VA, Silverman S, Recant W, et al.: An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J Clin Oncol 21, 4546-4552, 2003.
7. Kresty LA, Morse MA, Morgan C, Carlton PS, Lu J, et al.: Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res 61, 6112-6119, 2001.
8. Casto BC, Kresty LA, Kraly CL, Pearl DK, Knobloch TJ, et al.: Chemoprevention of oral cancer by black raspberries. Anticancer Res 22, 4005-4016, 2002.
9. Xue H, Aziz RM, Sun N, Cassady JM, Kamedulis LM, et al.: Inhibition of cellular transformation by berry extracts. Carcinogenesis 22, 351-356, 2001.
10. Huang C, Huang Y, Li J, Hu W, Aziz R, et al.: Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor KB by black raspberry extracts. Cancer Res 62, 6857-6863, 2002.
11. Stoner G, Sardo C, Apseloff G, Mullet D, Wargo W, et al.: Pharmacokinetic of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries for 7 days. J Clin Pharmacol 45, 1153-1164, 2005.
12. Kitadai Y, Onogawa S, Kuwai T, Matsumaura S, Hamada H, et al.: Anigogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma. Oncol Rep 11, 315-319, 2004.
13. Lingen MW: Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents. Crit Rev Oral Biol Med 10, 153-164, 1999.
14. Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, et al.: The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19, 711-721, 1998.
15. Rinaldi AL, Morse MA, Fields HW, Rothas DA, Pei P, et al.: Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa. Cancer Res 62, 5451-5456, 2002.
16. Mallery SR, Shenderova A, Pei P, Begum S, Ciminieri JR, et al.: Effects of 1-hydroxycamptothecin, delivered from locally injectable poly(lactide-co- glycolide) microspheres, in a murine human oral squamous cell carcinoma regression model. Anticancer Res 21, 1713-1722, 2001.
17. Mallery SR, Pei P, Kang J, Ness GM, Ortiz R, et al.: Controlled-release of doxorubicin from poly(lactide-co-glycolide) microspheres significantly enhances cytotoxicity against cultured AIDS-related Kaposi's sarcoma cells. Anticancer Res 20, 2817-2826, 2001.
18. Lowry OH, Rosebrough NJ, Fair AL, and Randall RJ: Protein measurement with the Polin phenol reagent. J Biol Chem 193, 265-275, 1951.
19. Losso JN, Bansode RR, Trappey A, Bawadi HA, and Truax R: In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 15, 672-678, 2004.
20. Masuda M, Suzui M, and Weinstein IB: Effects of epigallocatechin-3- gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 7, 4220-4229, 2001.
21. Aggarwal S, Takada Y, Singh S, Myers JN, and Aggarwal BB: Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-κB signaling. Int J Cancer 111, 679-692, 2004.
22. Soufla G, Sifakis S, Baritaki S, Zafiropoulos A, Koumantakis E, et al.: VEGF, FGF2, TGB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix. Cancer Lett 221, 105-118, 2005.
23. Schoeffher DJ, Matheny SL, Akahane T, Factor V, Berry A, et al.: VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms. Lab Invest 85, 608-623, 2005.
24. Smith BD, Smith GL, Carter D, Saski CT, and Haffty BG: Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 18, 2046-2052, 2000.
25. Singh RP, Tyagi AK, Shanalakshmi S, Agarwal R, and Agarwal C: Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3. Int J Cancer 108, 733-740, 2004.
26. Belotti D, Paganoni P, Manenti L, Garofalo A, Marchini S, et al.: Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implication for ascites formation. Cancer Res 63, 5224-5229, 2003.
27. Hou DX, Kai K, Li JJ, Lin S, Terahara N, et al.: Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms. Carcinogenesis 25, 29-36, 2004.
28. Mitsuke Y, Lee J-D, Shimizu H, Uzui H, Iwasaki H, et al.: Nitric oxide synthase activity in peripheral polymorphonuclear leukocytes in patients with chronic congestive heart failure. Am J Cardiol 87, 183-187, 2001.
29. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, et al.: Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. JNCI 90, 587-596, 1998.
30. Ohshima H and Bartsch H: Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 305, 253-264, 1994.
31. Burney S, Caulfield JL, Miles JC, Wishok JS, and Tannebaum SR: The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat Res 424, 37-49, 1999.
32. Joshi MS, Ponthier JL, and Lancaster JR: Cellular antioxidant and pro-oxidant actions of nitric oxide. Free Radic Biol Med 27, 1357-1366, 1999.
33. Rao CV: Nitric oxide signaling in colon cancer chemoprevention. Mutat Res 555, 107-119, 2004.
34. Kim DJ, Shin DH, Kang AB, Nam KT, Park CB, et al.: Chemoprevention of colon cancer by Korean food plant components. Mutat Res 523-524, 99-107, 2003.
35. Sturniolo MT, Dash SR, Deucher A, Rorke EA, Broome AM, et al.: A novel tumor suppressor protein promotes keratinocyte terminal differentiation via activation of type I transglutaminase. J Biol Chem 278, 48066-48073, 2003.
36. Ha Mai D and Bondy SC: Pro or anti-oxidant manganese: a suggested mechanism for reconciliation. Neurochem Int 44, 223-229, 2004.
37. Wlodek L: Beneficial and harmful effects of thiols. Pol J Pharmacol 54, 215-223, 2002.
38. Shilo S, Aronis A, Komarnitsky R, and Tirosh O: Selenite sensitizes mitochondrial permeability transition pore opening in vitro and in vivo: a possible mechanism for chemoprotection. Biochem J 15, 283-290, 2003.
39. Rorke EA and Jacobberger JW: Transforming growth factor-β1 enhances apoptosis in human papillomavirus type 16-immortalized human ectocervical epithelial cells. Exp Cell Res 216, 65-72, 1995.
40. Beninati S and Piacentini M: The transglutaminase family: an overview (minireview article). Amino Acids 26, 367-372, 2004.
41. Lentini A, Abbruzzese A, Caraglia M, Marra M, and Beninati S: Protein-polyamine conjugation by transglutaminase in cancer cell differentiation (review article). Amino Acids 26, 331-337, 2004.
42. Balasubramanian S, Sturniolo MT, Dubyak GR, and Eckert RL: Human epidermal keratinocytes undergo (-)-epigallocatechin-3-gallate differentiation but not apoptosis. Carcinogenesis 26, 1100-1108, 2005.